Guides

Read the filings like a pro.

Plain-English guides to the documents and events that move stocks: what each SEC form means, how to read insider trades, what analyst rating changes are worth, how FDA catalysts work, and how to act on news without getting burned.

SEC filings

How to read SEC filings: a practical guide to EDGAR and the forms that move stocksA plain-English guide to SEC filings: what each major form is, when it is due, where to find it on EDGAR, and which filings tend to matter most to investors.8 min read Form 8-K explained: every item number that matters to investorsWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.8 min read Form 10-K vs 10-Q: annual and quarterly reports explainedThe difference between a 10-K and a 10-Q: what each report contains, filing deadlines by company size, audited vs reviewed financials, and which sections to read first.7 min read Schedule 13D vs 13G: what 5% ownership filings tell youSchedule 13D vs 13G explained: who must file when crossing 5% ownership, the 2024 deadlines, how activists differ from passive holders, and what Item 4 reveals.7 min read Form S-1 and IPO filings: how to read a registration statementWhat a Form S-1 is, how the IPO filing sequence works from confidential draft to 424B4 final prospectus, and which S-1 sections reveal valuation, dilution and risk.7 min read Shelf offerings and dilution: how to read S-3s, 424B supplements, ATMs and warrantsHow shelf registrations, 424B prospectus supplements, at-the-market programs and warrants work, and how to spot share dilution in SEC filings before it hits the stock.7 min read Proxy statements (DEF 14A) explained: executive pay, board votes and shareholder proposalsWhat a DEF 14A proxy statement is, when it is filed, how to read executive pay and voting proposals, and which proxy items signal dilution, governance fights or deals.7 min read

Insiders and institutions

Trading the news

Earnings and dividends

Biotech and FDA

Market structure